Rheumatoid-arthritis drug Remicade price to be slashed

Janssen Korea said yesterday that its rheumatoid-arthritis medication Remicade 100 mg (infliximab) will be reduced by 3.9 percent to 557,332 won per bottle from Dec. 1 as the Ministry of Health and Welfare has decided to expand the coverage of the medication fee through the national health insurance.

“The price cut of Remicade will lessen patients’ financial burden to 725,000 won a year,” sa...